Relmada Therapeutics, Inc. (RLMD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 19.46M | 20.33M | 10.33M | 10.22M | 18.22M | 19.08M | 23.01M | 18.82M | 22.99M | 26.83M | 22.69M | 26.03M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.37M | 12.26M | 6.29M | 7.4M | 6.27M | 8.08M | 11.86M | 8.1M | 9.68M | 12.08M | 12.24M | 12.29M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 8.09M | 8.07M | 4.04M | 2.82M | 11.95M | 11M | 11.15M | 10.72M | 13.31M | 14.75M | 10.45M | 13.74M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.46M | -20.33M | -10.33M | -10.22M | -18.22M | -19.08M | -23.01M | -18.82M | -22.99M | -26.83M | -22.69M | -26.03M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -6.82% | -6.59% | 55.12% | 45.69% | 20.75% | 28.9% | -1.39% | 27.69% | 18.35% | 30.68% | 41.42% | 42.81% |
| EBITDA | -19.46M | -20.33M | -10.33M | -10.22M | -18.22M | 0 | -1K | 0 | -22.99M | 0 | -22.69M | -26.03M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -6.82% | - | -1032634.6% | - | 20.75% | - | 100% | 100% | 18.35% | 100% | 41.42% | 42.81% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 19.08M | 23.01M | 18.82M | 0 | 26.83M | 0 | 0 |
| EBIT | -19.46M | -20.33M | -10.33M | -10.22M | -18.22M | -19.08M | -23.01M | -18.82M | -22.99M | -26.83M | -22.69M | -26.03M |
| Net Interest Income | 959.76K | 387.23K | 247.01K | 321.46K | 440.29K | 654.64K | 856.48K | 963.01K | 1.06M | 1.26M | 1.32M | 1.36M |
| Interest Income | 959.76K | 387.23K | 247.01K | 321.46K | 440.29K | 654.64K | 856.48K | 963.01K | 1.06M | 1.26M | 1.32M | 1.36M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 409.8K | 465.35K | 235.85K | 354.86K | 658.97K | 418.42K | 1.28M | 1.05M | 1.16M | 1.66M | 690.58K | 723.77K |
| Pretax Income | -19.05M | -19.87M | -10.09M | -9.87M | -17.56M | -18.66M | -21.73M | -17.77M | -21.83M | -25.17M | -22M | -25.3M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -19.05M | -19.87M | -10.09M | -9.87M | -17.56M | -18.66M | -21.73M | -17.77M | -21.83M | -25.17M | -22M | -25.3M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -8.5% | -6.49% | 53.55% | 44.47% | 19.56% | 25.86% | 1.25% | 29.78% | 17.07% | 33.68% | 44.18% | 36.64% |
| Net Income (Continuing) | -19.05M | -19.87M | -10.09M | -9.87M | -17.56M | -18.66M | -21.73M | -17.77M | -21.83M | -25.17M | -22M | -25.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.22 | -0.29 | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 | -0.84 |
| EPS Growth % | 62.07% | 53.23% | 58.33% | 49.15% | 19.44% | 26.19% | 1.37% | 29.76% | 17.24% | 33.33% | 44.27% | 36.84% |
| EPS (Basic) | -0.22 | -0.29 | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 | -0.84 |
| Diluted Shares Outstanding | 86.6M | 68.26M | 33.19M | 33.19M | 30.41M | 30.17M | 30.17M | 30.17M | 30.13M | 30.1M | 30.1M | 30.1M |
| Basic Shares Outstanding | 86.6M | 68.26M | 33.19M | 33.19M | 30.41M | 30.17M | 30.17M | 30.17M | 30.13M | 30.1M | 30.1M | 30.1M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |